Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |